Advanced Filters
noise
Found 64,783 clinical trials
M MagTarmlab

Brachyspira and Intestinal Allergy-like Immune Reactions in Patients With Irritable Bowel Syndrome (IBS)

The aim of this study is to define local immune responses in the GI tract to food antigens in IBS patients, with and without Brachyspira infection, using advanced imaging. We hypothesize that Brachyspira infection can cause IBS symptoms by inducing loss of oral tolerance to dietary antigens through development of …

18 - 70 years of age All Phase N/A
A Ayman Hammad, MBBCh,MSc,MD

Effect of Sodium-glucose Cotransporter-2 Inhibitors (SGLT-2i) on Proteinuria in Nephrotic Children Older Than 10 Years

The goal of this clinical trial is to evaluate the effect of ACE inhibitors and SGLT-2 inhibitors on: Proteinuria Renal survival indices

10 - 18 years of age All Phase 4
S Sanaa Botros, Professor

The Effects of Different Loading Doses of Dexmedetomidine on The Bispectral Index-Guided Propofol Sedation in Patients Undergoing Advanced Upper Gastrointestinal Endoscopic Procedures: A Randomized Control Study

Propofol is currently the most common drug used but has drawbacks like narrow therapeutic window and potential complications. Dexmedetomidine is an attractive alternative due to its unique properties like minimal respiratory depression. Studies are ongoing to find the optimal use of dexmedetomidine for these procedures. A combination of propofol and …

18 - 65 years of age All Phase 4
F Feng Gao, Dr.

Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block

Efficacy of a modified auriculotemporal nerve blockade for patients undergoing supratentorial craniotomy Safety of a modified auriculotemporal nerve blockade for patients undergoing supratentorial craniotomy

18 - 65 years of age All Phase N/A
L Louise Fritsche, PhD

Prolactin Release Through Breast Stimulation in Non-lactating Women - Who Does Respond?

Prolactin is a multifunctional hormone which acts in different cell types rather than just modulating reproduction and lactation. One additional point is its action on glucose metabolism which is described especially in rodents. Prolactin affects proliferation, survival and insulin production of pancreatic beta cells in animal models. But also in …

18 - 45 years of age Female Phase N/A

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

To evaluate the efficacy of Surufatnib combined withcamrelizumab, nab-paclitaxel, and gemcitabine versus nab-paclitaxel plus gemcitabine as the first-line treatment in metastatic pancreatic cancer

18 - 75 years of age All Phase 2/3

A Study of FZ-AD004 in Patients With Advanced Solid Tumors

This study is one single group of participants with advanced solid tumors. It is the first time the drug has been used in humans. There will be two parts including Dose Escalation and Dose Expansion to evaluate the safety, tolerability, pharmacokinetics, and clinical activity of FZ-AD004.

18 - 75 years of age All Phase 1
Y Yang Liu

Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients With MIDD

This is an open-label, multicenter, Phase 2 study in subjects with newly diagnosed monoclonal immunoglobulin deposition disease treated with daratumumab, bortezomib, cyclophosphamide, and dexamethasone.

18 years of age All Phase 2
R Rafal Szylak, MBBS

Brief ES for Recovery of Autonomic Function in CES

BESCES is a study that aims to explore the feasibility of intraoperative brief epidural electrical stimulation (ES) for patients undergoing routine decompression for cauda equina syndrome. In consenting patients, brief ES will be applied using a CE-marked SCS trial kit once sufficient decompression is achieved. In participants who do not …

18 years of age All Phase N/A

Effects of an Omega-3 Fatty Acid-based Supplement on Healthy Ageing

The goal of this randomised, double-blind placebo controlled trial is to explore tolerability and the effects of a new omega-3 fatty acid-based supplement on biological and clinical aspects relevant for healthy ageing. Participants will be asked to take a supplement or a placebo for 6 months, and to attend the …

55 - 100 years of age All Phase N/A

Simplify language using AI